Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in Compr Psychiatry

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    October 2022
  1. VASS E, Simon V, Csukly G, Fekete Z, et al
    Virtual reality-based theory of mind intervention in schizophrenia: Preliminary efficacy results.
    Compr Psychiatry. 2022;119:152350.
    PubMed     Abstract available


  2. RODRIGUEZ-TESTAL JF, Fuentes-Marquez S, Senin-Calderon C, Fernandez-Leon S, et al
    Validation of the aberrant salience inventory in a general and clinical Spanish population.
    Compr Psychiatry. 2022;118:152343.
    PubMed     Abstract available


    July 2022
  3. BIEDERMANN F, Kurzthaler I, Haibach M, Pardeller S, et al
    Driving fitness in clinically stable outpatients with chronic schizophrenia.
    Compr Psychiatry. 2022;118:152340.
    PubMed     Abstract available


  4. RAJENDRAN P, Van Winssen C, Viswasam K, Tariq N, et al
    The psychometric properties of the Nepean Belief Scale as a tool for assessing delusions in schizophrenia and related psychotic disorders.
    Compr Psychiatry. 2022;117:152337.
    PubMed     Abstract available


    May 2022
  5. WIDING L, Simonsen C, Flaaten CB, Haatveit B, et al
    Premorbid characteristics of patients with DSM-IV psychotic disorders.
    Compr Psychiatry. 2022;115:152310.
    PubMed     Abstract available


    March 2022
  6. NADESALINGAM N, Chapellier V, Lefebvre S, Pavlidou A, et al
    Motor abnormalities are associated with poor social and functional outcomes in schizophrenia.
    Compr Psychiatry. 2022;115:152307.
    PubMed     Abstract available


  7. GE F, Huo Z, Liu Y, Du X, et al
    Association between schizophrenia and prostate cancer risk: Results from a pool of cohort studies and Mendelian randomization analysis.
    Compr Psychiatry. 2022;115:152308.
    PubMed     Abstract available


    February 2022
  8. JAYA ES, Pillny M, Lincoln TM, Riehle M, et al
    Does social defeat cause negative symptoms? A prospective study in a multi-national community sample.
    Compr Psychiatry. 2022;113:152289.
    PubMed     Abstract available


    November 2021
  9. DORFLINGER C, LeHew C, Carey H, Roche-Desilets J, et al
    Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients.
    Compr Psychiatry. 2021;111:152269.
    PubMed    


    October 2021
  10. AISSA A, Jouini R, Ouali U, Zgueb Y, et al
    Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia.
    Compr Psychiatry. 2021;112:152280.
    PubMed     Abstract available


    July 2021
  11. HE XY, Hou CL, Huang ZH, Huang YH, et al
    Individuals at ultra-high risk of psychosis and first-degree relatives of patients with schizophreniaexperience impaired family functionality and social support deficit in comparison to healthy controls.
    Compr Psychiatry. 2021;109:152263.
    PubMed     Abstract available


  12. NAVARRA-VENTURA G, Vicent-Gil M, Serra-Blasco M, Massons C, et al
    Group and sex differences in social cognition in bipolar disorder, schizophrenia/schizoaffective disorder and healthy people.
    Compr Psychiatry. 2021;109:152258.
    PubMed     Abstract available


    June 2021
  13. MEDIAVILLA R, Lopez-Arroyo M, Gomez-Arnau J, Wiesepape C, et al
    Autobiographical memory in schizophrenia: The role of metacognition.
    Compr Psychiatry. 2021;109:152254.
    PubMed     Abstract available


    April 2021
  14. PARK HY, Seo E, Park KM, Koo SJ, et al
    Shame and guilt in youth at ultra-high risk for psychosis.
    Compr Psychiatry. 2021;108:152241.
    PubMed     Abstract available


  15. VEGA D, Acosta FJ, Saavedra P
    Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up study.
    Compr Psychiatry. 2021;108:152240.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: